545 related articles for article (PubMed ID: 31112866)
1. HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells.
Teng R; Liu Z; Tang H; Zhang W; Chen Y; Xu R; Chen L; Song J; Liu X; Deng H
Redox Biol; 2019 Jun; 24():101218. PubMed ID: 31112866
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of HSP60 disrupts mitochondrial proteostasis to promote tumorigenesis and progression in clear cell renal cell carcinoma.
Tang H; Chen Y; Liu X; Wang S; Lv Y; Wu D; Wang Q; Luo M; Deng H
Oncotarget; 2016 Jun; 7(25):38822-38834. PubMed ID: 27246978
[TBL] [Abstract][Full Text] [Related]
3. SIRT3 Overexpression Inhibits Growth of Kidney Tumor Cells and Enhances Mitochondrial Biogenesis.
Liu H; Li S; Liu X; Chen Y; Deng H
J Proteome Res; 2018 Sep; 17(9):3143-3152. PubMed ID: 30095923
[TBL] [Abstract][Full Text] [Related]
4. The 60-kDa heat shock protein regulates energy rearrangement and protein synthesis to promote proliferation of multiple myeloma cells.
Wu X; Guo J; Chen Y; Liu X; Yang G; Wu Y; Tian Y; Liu N; Yang L; Wei S; Deng H; Chen W
Br J Haematol; 2020 Sep; 190(5):741-752. PubMed ID: 32155663
[TBL] [Abstract][Full Text] [Related]
5.
Xu J; Zhu S; Xu L; Liu X; Ding W; Wang Q; Chen Y; Deng H
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824856
[TBL] [Abstract][Full Text] [Related]
6. HSP60-regulated Mitochondrial Proteostasis and Protein Translation Promote Tumor Growth of Ovarian Cancer.
Guo J; Li X; Zhang W; Chen Y; Zhu S; Chen L; Xu R; Lv Y; Wu D; Guo M; Liu X; Lu W; Deng H
Sci Rep; 2019 Sep; 9(1):12628. PubMed ID: 31477750
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of HSP60 Suppresses the Proliferation of Glioblastoma Cells via the ROS/AMPK/mTOR Pathway.
Tang H; Li J; Liu X; Wang G; Luo M; Deng H
Sci Rep; 2016 Jun; 6():28388. PubMed ID: 27325206
[TBL] [Abstract][Full Text] [Related]
8. The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma.
Wang J; Zhang P; Zhong J; Tan M; Ge J; Tao L; Li Y; Zhu Y; Wu L; Qiu J; Tong X
Oncotarget; 2016 May; 7(19):27142-57. PubMed ID: 27049827
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target.
Gerlinger M; Santos CR; Spencer-Dene B; Martinez P; Endesfelder D; Burrell RA; Vetter M; Jiang M; Saunders RE; Kelly G; Dykema K; Rioux-Leclercq N; Stamp G; Patard JJ; Larkin J; Howell M; Swanton C
J Pathol; 2012 Jun; 227(2):146-56. PubMed ID: 22362593
[TBL] [Abstract][Full Text] [Related]
11. Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate.
Nilsson H; Lindgren D; Mandahl Forsberg A; Mulder H; Axelson H; Johansson ME
Cell Death Dis; 2015 Jan; 6(1):e1585. PubMed ID: 25569102
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth.
Zhou C; Sun H; Zheng C; Gao J; Fu Q; Hu N; Shao X; Zhou Y; Xiong J; Nie K; Zhou H; Shen L; Fang H; Lyu J
Cell Death Dis; 2018 Feb; 9(2):161. PubMed ID: 29415987
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma.
Reustle A; Menig LS; Leuthold P; Hofmann U; Stühler V; Schmees C; Becker M; Haag M; Klumpp V; Winter S; Büttner FA; Rausch S; Hennenlotter J; Fend F; Scharpf M; Stenzl A; Bedke J; Schwab M; Schaeffeler E
Clin Transl Med; 2022 Jun; 12(6):e883. PubMed ID: 35678045
[TBL] [Abstract][Full Text] [Related]
15. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
16. NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma.
Kubala JM; Laursen KB; Schreiner R; Williams RM; van der Mijn JC; Crowley MJ; Mongan NP; Nanus DM; Heller DA; Gudas LJ
Cancer Biol Ther; 2023 Dec; 24(1):2170669. PubMed ID: 36722045
[TBL] [Abstract][Full Text] [Related]
17. UQCRH downregulation promotes Warburg effect in renal cell carcinoma cells.
Luo Y; Medina Bengtsson L; Wang X; Huang T; Liu G; Murphy S; Wang C; Koren J; Schafer Z; Lu X
Sci Rep; 2020 Sep; 10(1):15021. PubMed ID: 32929120
[TBL] [Abstract][Full Text] [Related]
18. Isotope tracing assisted metabolic profiling: Application to understanding HSP60 silencing mediated tumor progression.
Tang H; Teng R; Zhao X; Wang X; Xu L; Deng H; Liu X
Anal Chim Acta; 2019 Jan; 1047():93-103. PubMed ID: 30567669
[TBL] [Abstract][Full Text] [Related]
19. GYS1 induces glycogen accumulation and promotes tumor progression via the NF-κB pathway in Clear Cell Renal Carcinoma.
Chen SL; Huang QS; Huang YH; Yang X; Yang MM; He YF; Cao Y; Guan XY; Yun JP
Theranostics; 2020; 10(20):9186-9199. PubMed ID: 32802186
[TBL] [Abstract][Full Text] [Related]
20. Analyses of the transcriptome and metabolome demonstrate that HIF1α mediates altered tumor metabolism in clear cell renal cell carcinoma.
Minton DR; Fu L; Chen Q; Robinson BD; Gross SS; Nanus DM; Gudas LJ
PLoS One; 2015; 10(4):e0120649. PubMed ID: 25830305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]